It is that clogging of the board that makes you mi

It is that clogging of the board that makes you miss these concepts... They've been stated over and over for weeks. You're in good company, too, before you start feeling that you're being singled out... No shortage of compatriots.

See:

Quote:

---

I've brought this up every other week, got tired of repeating it, but we are at the point where reference viruses / spike proteins used for these vaccines and therapeutics may be outdated as active hosts have seen a massive increase... Opportunities for [mutation] variation in transmission and lethality are increasing as well. Only one strategy remains agnostic to virus mutations, and that is immune modulation.

And only one therapeutic appears ideally suited for immune modulation. Leronlimab.


Read More: https://investorshangout.com/post/view?id=599...z6ijpvJUck

---

And

Quote:

---

Time is of the essence... Increased nasopharyngeal proliferation = increased viral load on transmission = likely worse disease progression / clinical outcomes.

The current vaccines will not roll out fast enough and wide enough to halt the pandemic; all they will do is select for a mutated virus that the vaccinated won't be protected against, which will become the dominant strain, and likely be able to infect those that have already been infected. At that point, hyperimmunity becomes a huge concern... will the second time around, with a similar but not quite the same strain, result in increased severity / death, like Dengue?


{'No' reason? Try again, Vivek. That specific strain, perhaps, but that strain is set to increase spread and thus, mutation frequency... It's grandchildren will likely be the ones to overcome vaccination}

Read More: https://investorshangout.com/post/view?id=600...z6ijqYQZBd

---